Refine your search

Content type
Tags
Firm name
Author
Jurisdiction
Language

545 results found

Article
Ask Lexy

McDermott Will & Emery | USA | 20 Oct 2022

When Are Compulsory Copyright Licenses Compulsory?

The US Court of Appeals for the Second Circuit partially affirmed a district court’s summary judgment order holding that audiovisual recordings of…
Article
Ask Lexy

Gün + Partners | Turkey | 11 Oct 2022

Why compulsory licensing is a blunt instrument in the post-covid landscape

Earlier this year the Turkish minister of health announced that President Recep Tayyip Erdogan had made a compulsory licence decision about the…
Commentary
Ask Lexy

IP Law Galli | Italy | 27 Jun 2022

Revision of Italian IP code: university patents return to universities and digitisation continues

The Italian Council of Ministers has approved a draft law to amend several provisions of the Industrial Property Code. Some significant potential novelties concerning administrative simplification and digitisation of procedures have to be pointed out. Even more significant – albeit in need of improvement – is the restitution to universities (both public and private) and other public research......
Article
Ask Lexy

Van Bael & Bellis | Belgium | 23 Jun 2022

Belgian Government Think-Tank Publishes Study on Compulsory Licensing for Expensive Medicines

On 14 June 2022, the Belgian Health Care Knowledge Centre (KCE), a research institute funded by the federal government, published a study discussing…
Commentary
Ask Lexy

Mirandah Asia | Thailand | 22 Nov 2021

Thailand rejects covid-19 drug granted by European Patent Office and US Patent and Trademark Office

Favipiravir is a broad-spectrum antiviral drug used in the treatment of multiple diseases and is the first drug that has been approved by various countries as an emergency treatment for covid-19. Thailand's Department of Intellectual Property has rejected a Thai patent application filed under the compulsory licence system for a specific formulation of Favipiravir in tablet form.
Analysis PRO In-house
Ask Lexy

Lexology PRO | Australia, New Zealand | 9 Jul 2021

New Zealand to establish consumer data right framework

New Zealand’s government has agreed to establish a consumer data right framework in order to give individuals and businesses greater choice and control over their data.
Article
Ask Lexy

Taylor Wessing | Germany | 7 Apr 2020

Zwangslizenzen und staatliche Benutzungsanordnungen für Patente

Einschränkungen für Patentinhaber zur Wahrung des öffentlichen Interesses an der ausreichenden Verfügbarkeit notwendiger Arzneimittel Prinzip: Der…
Article
Ask Lexy

Baker McKenzie | Indonesia | 22 Apr 2019

Indonesia - MOLHR Issues Regulation on Procedure for Grant of Patent Compulsory License

On 28 December last year, the Ministry of Law and Human Rights issued a regulation on the procedure for grant of patent compulsory licenses. The…
Article
Ask Lexy

Cooley LLP | USA | 15 Mar 2019

Medicare for All unveiled in House. Some things old, some things new, but much left to do

Recently, progressive Democrats in the House of Representatives lead by Rep. Pramila Jayapal (D-WA) and Debbie Dingell (D-MI) released the…
Article
Ask Lexy

Matheson | European Union, Ireland, United Kingdom | 14 Mar 2019

BREXIT and Intellectual Property - Patents

Much as we at Matheson would prefer a sensible deal, which provides certainty to organisations with business interests in the United Kingdom, it is…
Previous page 1 2 3 ...